Jazz (JAZZ) EVP & Chief Legal Officer Neena Patil Sells 1,200 Shares

What Happened
Neena M. Patil, EVP and Chief Legal Officer of Jazz Pharmaceuticals (JAZZ), reported a sale of 1,200 shares on September 10, 2026. The shares were disposed at $240.94 per share, for a total value of $289,128. This was a sale (not a purchase) and is commonly a routine liquidity event rather than a direct signal of company outlook.

Key Details

• Transaction date: September 10, 2026
• Transaction type/code: Open-market or private sale (S) — reported as open-market sale
• Price per share: $240.94
• Total proceeds: $289,128
• Shares owned after transaction: Not specified in this filing
• Footnote: Reported under a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2026; the sale occurred automatically under that plan and was not a discretionary trade (Footnote F1)
• Filing timeliness: Form 4 filed on September 14, 2026 (reported within required filing window)

Context
A 10b5-1 plan indicates the trade was pre-arranged and automated, which is important context for retail investors because such sales are often scheduled for routine reasons (taxes, diversification, liquidity) rather than an immediate change in insider sentiment. Sales provide less clear signals than purchases, so interpret this as a factual disclosure of an insider liquidity event.